Exercise for the Treatment of Cancer-Related Sarcopenia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorState University of Londrina
About this trial
Our primary objective is to assess the effects of exercise on cancer-related sarcopenia and its hallmarks, including muscle strength, muscle mass, and physical performance. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (QoL), cancer-related fatigue, and sleep quality. Additionally, we will explore the effects of exercise on bone and fat mass as secondary outcomes.
Eligibility criteria
Qualifiers
> 18 years old women with a confirmed diagnosis of breast or gynecological cancer.
Any level of sarcopenia (pre-sarcopenia, sarcopenia, or severe sarcopenia).
Patients must have completed their primary treatment regimen (surgery, chemotherapy, and/or radiotherapy) for at least 2 weeks and up to 2 years before enrolment.
have received the medical consent to be engaged in physical exercise programs.
Disqualifiers
The presence of one or more comorbidities that could potentially interfere with attendance or test results (e.g., other cancers or acute or chronic renal failure);
Already in exercise programs comparable to the HERA program;
Evidence of severe cardiovascular disease as a result of an electrocardiogram.
Trial design
Treatments tested in this trial
- Multimodal, supervised exercise training
Treatment groups
78 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov